Czech blood plasma saga leads to treaty claim
Scenic Prague, location of TMA's East European Conference 2016 (Credit: iStock/Deejpilot)
The Czech Republic is facing a billion-dollar investment treaty claim arising from a two-decade dispute with a blood plasma supplier whose efforts to enforce a US$650 million award against the state have been repeatedly thwarted.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now